MGE Innovation Center Tenants
 
State Journal marks Research Park's birth
November 17, 2008
It was 25 years ago this fall that the UW Board of Regents approved pursuing the creation of University Research Park. That anniversary was marked during the Nov. 5-6 Wisconsin Early Stage Symposium and celebrated in a Nov. 17 editorial in the Wisconsin State Journal.

...........................................

Tech Council board chairman Bugher wins top service award from Marshfield Clinic
November 10, 2008
EAU CLAIRE – Citing his volunteer service to the Marshfield Clinic and the communities it serves, the Marshfield Clinic Heritage Foundation has singled out Mark Bugher for its highest annual award.

...........................................

Kikkoman USA’s announces new research and development laboratory in University Research Park
Sept. 9, 2008
The laboratory, which will join Kikkoman’s global research and development network, will foster increased collaboration between the company and University of Wisconsin-Madison food science researchers
.

...........................................

New ‘urban research park’ offers jolt of electricity to Madison high-tech startups
August 4, 2008
After three decades of almost exponential commercial growth on Madison's west side, the University Research Park (URP) will pursue an opportunity to sink roots downtown with an innovative "urban research park" targeting high-technology entrepreneurs.

...........................................

Return...

Helix Diagnostics LLC

Contact Name:  James Timmins
Contact Phone:  608.277.0791
Contact Email:  jim@helixdiagnostics.com
Address:  510 Charmany Drive, Suite 62
City:  Madison
State:  WI
Zip Code:  53719
Website:  http://www.helixdiagnostics.com/


Categories: 
Life / BIO Sciences
Pharmaceuticals


Helix Diagnostics LLC is pursuing development and commercialization of multiplexed DNA detection systems based on capillary electrophoresis.

Helix is a specialty bioanalytical CRO that offers direct DNA/RNA detection services for developers of oligonucleotide therapeutics (RNAi, microRNA, antisense). Helix Diagnostics® methods provide, in the same assay, both identification and quantitation of the target RNA/DNA and any relevant metabolites from Clients' tox and clinical samples. Our company was founded on exclusive licenses to patents covering the combination of hybridization and capillary electrophoresis.